Dissociated expression of bcl-2 and Ki-67 in endometrial lesions: Diagnostic and histogenetic implications

International Journal of Gynecological Pathology

Volumn 21, Issue 2, 2002, Pages 155-160

  Risberg, Björn ^a   Karlsson, Kerstin ^a   Abeler, Vera ^a   Lagrelius, Anders ^a   Davidson, Ben ^a   Karlsson, Mats G ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Apoptosis; Endometrial carcinoma; Endometrial hyperplasia; Proliferation

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

EID: 0036205381     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200204000-00008     Document Type: Article

References (31)

1. Estrogens and endometrial carcinoma
2. Exogenous estrogen and endometrial carcinoma: Case-control and incidence study
3. Association of exogenous estrogen and endometrial carcinoma
4. Endometrial glandular proliferation and estrogen receptor content during the normal menstrual cycle
5. Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium
6. Apoptosis in the endometrium
7. Bcl-2 expression in normal endometrium during the menstrual cycle
8. Dating the endometrial biopsy
9. Progressing imbalance between proliferation and apoptosis with increasing severity of cervical neoplasia
10. Bcl-2 expression is correlated with low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas
11. Site and menstrual cycle-dependent expression of proteins of the TNF receptor family, and BCL-2 oncoprotein and phase specific production of TNF-α in human endometrium
12. Elevated expression of the proapoptotic BCL-2 family member, BAK, in the human endometrium coincident with apoptosis during the secretory phase of the cycle
13. Apoptosis and apoptosis-related proteins in human endometrium
14. Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas
15. Down-regulation of Bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia
16. The patterns of an apoptosis-related CD18 neoeptitope, the bcl-2 proto-oncogene, and the Ki-67 proliferation marker in normal, hyperplastic, and malignant endometrium
17. Bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma
18. Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma
19. Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions
20. Bcl-2 expression in endometrial hyperplasia and carcinoma
21. Bcl-2 expression and the development of endometrial carcinoma
22. Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity
23. Bcl-2 and p53 in endometrial adenocarcinoma
24. Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria
25. Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium
26. Simple hyperplasia of the endometrium: An evaluation of proliferative activity by Ki-67 immunostaining
27. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium
28. Fatty acid synthase in endometrial carcinoma. Correlation with cell proliferation and hormone receptors
29. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma
30. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens